120
Participants
Start Date
March 31, 1999
Primary Completion Date
March 31, 1999
Study Completion Date
March 31, 1999
Nelfinavir mesylate
Stavudine
Didanosine
Anderson Clinical Research Inc, Rego Park
Anderson Clinical Research Inc, Reading
Coastal Carolina Research Ctr, Mt. Pleasant
South Shore Hosp, Miami
Community Health Care, Fort Lauderdale
Immunity Care and Research Inc, Fort Lauderdale
HIV Clinical Research Ctr, Fort Lauderdale
Saint Josephs Comprehensive Research Institute, Tampa
Sorra Research Ctr / Med Forum, Birmingham
Chicago Ctr for Clinical Research, Chicago
Oak Lawn Physicians Group, Dallas
Nicholaos Bellos, Dallas
Houston Clinical Research Network / Div of Montrose Clinic, Houston
Beacon Clinic / Boulder Community Hosp, Boulder
Clinical Studies of Las Vegas, Las Vegas
Robert Scott MD, Oakland
Swedish Med Ctr, Seattle
AIDS Research Consortium of Atlanta, Atlanta
Univ of Kansas School of Medicine, Wichita
Univ of Nebraska Med Ctr, Omaha
Univ of Texas Southwestern Med Ctr of Dallas, Dallas
AIDS Healthcare Foundation, Los Angeles
Clinique Medicale du Quartier Latin, Montreal
Clinique Medicale L'Actuele, Montreal
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY